Wen Wei Chung

417 total citations
9 papers, 329 citations indexed

About

Wen Wei Chung is a scholar working on Geriatrics and Gerontology, Family Practice and Molecular Biology. According to data from OpenAlex, Wen Wei Chung has authored 9 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Geriatrics and Gerontology, 4 papers in Family Practice and 2 papers in Molecular Biology. Recurrent topics in Wen Wei Chung's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Medication Adherence and Compliance (4 papers) and Cancer Mechanisms and Therapy (2 papers). Wen Wei Chung is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Medication Adherence and Compliance (4 papers) and Cancer Mechanisms and Therapy (2 papers). Wen Wei Chung collaborates with scholars based in Malaysia, Taiwan and Australia. Wen Wei Chung's co-authors include Pauline Siew Mei Lai, Siew Siang Chua, Siew Pheng Chan, W Y Lui, Feng Peng, Adeeba Kamarulzaman, Shahrul Bahyah Kamaruzzaman, Donald E. Morisky, Li Min Lim and Reena Rajasuriar and has published in prestigious journals such as PLoS ONE, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Oncology Reports.

In The Last Decade

Wen Wei Chung

9 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Wei Chung Malaysia 8 122 74 68 48 46 9 329
Catherine I. Starner United States 9 74 0.6× 91 1.2× 34 0.5× 160 3.3× 52 1.1× 15 345
Noriko Fukushima Japan 11 58 0.5× 16 0.2× 61 0.9× 13 0.3× 35 0.8× 49 382
Alberto Costantini Italy 9 23 0.2× 60 0.8× 26 0.4× 37 0.8× 14 0.3× 31 263
Jinhai Shi China 7 64 0.5× 65 0.9× 60 0.9× 66 1.4× 14 0.3× 8 457
Pauline Bosco‐Lévy France 13 23 0.2× 24 0.3× 56 0.8× 32 0.7× 19 0.4× 31 399
Li‐Na Kuo Taiwan 10 40 0.3× 16 0.2× 80 1.2× 13 0.3× 14 0.3× 24 342
Nancy Luo United States 12 41 0.3× 29 0.4× 136 2.0× 36 0.8× 33 0.7× 24 600
Ibrahim E. Fahdi United States 7 105 0.9× 155 2.1× 29 0.4× 55 1.1× 20 0.4× 9 400

Countries citing papers authored by Wen Wei Chung

Since Specialization
Citations

This map shows the geographic impact of Wen Wei Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Wei Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Wei Chung more than expected).

Fields of papers citing papers by Wen Wei Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Wei Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Wei Chung. The network helps show where Wen Wei Chung may publish in the future.

Co-authorship network of co-authors of Wen Wei Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Wei Chung. A scholar is included among the top collaborators of Wen Wei Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Wei Chung. Wen Wei Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Lai, Pauline Siew Mei, et al.. (2018). Development and validation of an Ambulatory Care Patient Satisfaction Questionnaire to assess pharmacy services in Malaysia. International Journal of Clinical Pharmacy. 40(5). 1309–1316. 7 indexed citations
3.
Lim, Li Min, Wen Wei Chung, Adeeba Kamarulzaman, et al.. (2017). Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. PLoS ONE. 12(3). e0173466–e0173466. 99 indexed citations
4.
Chung, Wen Wei, Siew Siang Chua, Pauline Siew Mei Lai, & Donald E. Morisky. (2015). The Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia. PLoS ONE. 10(4). e0124275–e0124275. 33 indexed citations
5.
Chung, Wen Wei, et al.. (2014). Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Preference and Adherence. 8. 1185–1185. 49 indexed citations
6.
Chua, Siew Siang, et al.. (2013). THE DEVELOPMENT AND VALIDATION OF THE MALAYSIAN MEDICATION ADHERENCE SCALE (MALMAS) AMONG PATIENTS WITH 2 TYPE DIABETES IN MALAYSIA. 11 indexed citations
7.
Lin, Wen‐chang, et al.. (1999). tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer.. PubMed. 5(7). 1745–51. 48 indexed citations
8.
Wu, Cheng-Han, et al.. (1998). Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma.. Oncology Reports. 5(4). 817–22. 49 indexed citations
9.
Wu, Chew Wun, Hsien‐Li Kao, W Y Lui, et al.. (1996). Immunohistochemical study of arginase in cancer of the stomach. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 428(6). 325–31. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026